Comparison of B-mode ultrasound, 3-dimensional ultrasound, and magnetic resonance imaging measurements of carotid atherosclerosis

Journal of Ultrasound in Medicine

Volumn 27, Issue 9, 2008, Pages 1321-1334

  Egger, Micaela ^a   Krasinski, Adam ^a,b   Rutt, Brian K ^a,b   Fenster, Aaron ^a,b   Parraga, Grace ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Carotid artery; Magnetic resonance imaging; Stroke; Ultrasound

Indexed keywords

DISEASES; MAGNETISM; RESONANCE; ULTRASONIC APPLICATIONS; ULTRASONICS;

CAROTID ARTERY; COEFFICIENTS OF VARIATIONS; HIGH SENSITIVITY; INTIMA-MEDIA THICKNESS; REPRODUCIBILITIES; SINGLE OBSERVER; STROKE; THREE-DIMENSIONAL MEASUREMENTS;

MAGNETIC RESONANCE IMAGING;

AGED; ARTERIAL WALL THICKNESS; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B SCAN; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; REPRODUCIBILITY; THREE DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 54149103059     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2008.27.9.1321     Document Type: Article

References (50)

1. Golledge J, Greenhalgh RM, Davies AH. The symptomatic carotid plaque. Stroke 2000; 31:774-781.
2. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340:14-22.
3. Spence JD, Eliasziw M, DiCicco M, Hackam DG, Galil R, Lohmann T. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke 2002; 33:2916-2922.
4. Kanters SD, Algra A, van Leeuwen MS, Banga JD. Reproducibility of in vivo carotid intima-media thickness measurements: a review. Stroke 1997; 28:665-671.
5. Hodis HN, Mack WJ, LaBree L, et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med 1996; 124:548-556.
6. Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998; 128:262-269.
7. Bots ML, Evans GW, Riley WA, Grobbee DE. Carotid intimamedia thickness measurements in intervention studies: design options, progression rates, and sample size considerations - a point of view. Stroke 2003; 34:2985-2994.
8. Yuan C, Kerwin WS, Yarnykh VL, et al. MRI of atherosclerosis in clinical trials. NMR Biomed 2006; 19:636-654.
9. Nelson TR, Downey DB, Pretorius DH, Fenster A. Three-Dimensional Ultrasound. Philadelphia, PA: Lippincott Williams & Wilkins; 1999.
10. Spence JD. Point: uses of carotid plaque measurement as a predictor of cardiovascular events. Prev Cardiol 2005; 8:118-121.
11. Spence JD. Technology Insight: ultrasound measurement of carotid plaque - patient management, genetic research, and therapy evaluation. Nat Clin Pract Neurol 2006; 2:611-619.
12. Al Shali K, House AA, Hanley AJ, et al. Differences between carotid wall morphological phenotypes measured by ultrasound in one, two, and three dimensions. Atherosclerosis 2005; 178:319-325.
13. Al Shali KZ, House AA, Hanley AJ, et al. Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis. Stroke 2004; 35:2036-2040.
14. Pollex RL, Hegele R. Genetic determinants of carotid ultrasound traits. Curr Atheroscler Rep 2006; 8:206-215.
15. Riccio SA, House AA, Spence JD, Fenster A, Parraga G. Carotid ultrasound phenotypes in vulnerable populations. Cardiovasc Ultrasound 2006; 4:44.
16. Spence JD, Hegele RA. Noninvasive phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24:e188-e189.
17. Spence JD, Hegele RA. Noninvasive phenotypes of atherosclerosis: similar windows but different views. Stroke 2004; 35:649-653.
18. Spence JD. Measurement of intima-media thickness vs. carotid plaque: uses in patient care, genetic research and evaluation of new therapies. Int J Stroke 2006; 1:216-221.
19. Pollex RL, Spence JD, House AA, et al. A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes. Cardiovasc Ultrasound 2005; 3:15.
20. Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD. 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke 2005; 36:1904-1909.
21. Fenster A, Downey DB, Cardinal HN. Three-dimensional ultrasound imaging. Phys Med Biol 2001; 46:R67-R99.
22. Landry A, Spence JD, Fenster A. Measurement of carotid plaque volume by 3-dimensional ultrasound. Stroke 2004; 35:864-869.
23. Underhill HR, Kerwin WS, Hatsukami TS, Yuan C. Automated measurement of mean wall thickness in the common carotid artery by MRI: a comparison to intima-media thickness by B-mode ultrasound. J Magn Reson Imaging 2006; 24:379-387.
24. Selzer RH, Hodis HN, Kwong-Fu H, et al. Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis 1994; 111:1-11.
25. Egger M, Spence JD, Fenster A, Parraga G. Validation of 3D ultrasound vessel wall volume: an imaging phenotype of carotid atherosclerosis. Ultrasound Med Biol 2007; 33:905-914.
26. Landry A, Fenster A. Theoretical and experimental quantification of carotid plaque volume measurements made by three-dimensional ultrasound using test phantoms. Med Phys 2002; 29:2319-2327.
27. Saam T, Kerwin WS, Chu B, et al. Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. J Cardiovasc Magn Reson 2005; 7:799-808.
28. Howell DC. Fundamental Statistics for the Behavioural Sciences. Belmont, CA: Brooks/Cole-Thomas Learning Inc; 2004.
29. Landry A, Spence JD, Fenster A. Quantification of carotid plaque volume measurements using 3D ultrasound imaging. Ultrasound Med Biol 2005; 31:751-762.
30. Saam T, Yuan C, Chu B, et al. Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis 2007; 194:e34-e42.
31. Varghese A, Crowe LA, Mohiaddin RH, et al. Interstudy reproducibility of three-dimensional volume-selective fast spin echo magnetic resonance for quantifying carotid artery wall volume. J Magn Reson Imaging 2005; 21:187-191.
32. Varghese A, Crowe LA, Mohiaddin RH, et al. Inter-study reproducibility of 3D volume selective fast spin echo sequence for quantifying carotid artery wall volume in asymptomatic subjects. Atherosclerosis 2005; 183:361-366.
33. Barnett PA, Spence JD, Manuck SB, Jennings JR. Psychological stress and the progression of carotid artery disease. J Hypertens 1997; 15:49-55.
34. Spence JD. Measuring effects of antiatherosclerotic therapies. J Am Coll Cardiol 2006; 48:845-846.
35. Adams GJ, Greene J, Vick GW III, et al. Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imaging. Magn Reson Imaging 2004; 22:1249-1258.
36. Mercié P, Thiébaut R, Aurillac-Lavignolle V, et al. Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients. HIV Med 2005; 6:380-387.
37. Vicenzini E, Ricciardi MC, Puccinelli F, et al. Common carotid artery intima-media thickness determinants in a population study. J Ultrasound Med 2007; 26:427-432.
38. Lemne C, Jogestrand T, de Faire U. Carotid intima-media thickness and plaque in borderline hypertension. Stroke 1995; 26:34-39.
39. Aminbakhsh A, Mancini GB. Carotid intima-media thickness measurements: what defines an abnormality? A systematic review. Clin Invest Med 1999; 22:149-157.
40. de Groot E, Jukema JW, Montauban van Swijndregt AD, et al. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol 1998; 31:1561-1567.
41. Fan AZ, Dwyer JH. Sex differences in the relation of HDL cholesterol to progression of carotid intima-media thickness: the Los Angeles Atherosclerosis Study. Atherosclerosis 2007; 195:e191-e196.
42. Hedblad B, Zambanini A, Nilsson P, Janzon L, Berglund G. Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study. J Intern Med 2007; 261:293-305.
43. Kastelein JJ, Sager PT, de Groot E, Veltri E. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hyper-cholesterolemia: design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial. Am Heart J 2005; 149:234-239.
44. Kastelein JJ, van Leuven SI, Burgess L, et al. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med 2007; 356:1620-1630.
45. Wang JG, Staessen JA, Li Y, et al. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke 2006; 37:1933-1940.
46. Hodis HN, Mack WJ, Lobo RA, et al. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001; 135:939-953.
47. Hodis HN, Mack WJ. Atherosclerosis imaging methods: assessing cardiovascular disease and evaluating the role of estrogen in the prevention of atherosclerosis. Am J Cardiol 2002; 89:19E-27E.
48. Taylor AJ, Sullenberger LE, Lee HJ, Lee JK, Grace KA. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 2004; 110:3512-3517.
49. Zheng L, Hodis HN, Buchanan TA, Li Y, Mack WJ. Effect of antihypertensive therapy on progression of carotid intimamedia thickness in patients with type 2 diabetes mellitus. Am J Cardiol 2007; 99:956-960.
50. Corti R, Fuster V, Fayad ZA, et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol 2005; 46:106-112.